Related Experiment Video

Updated: Jun 16, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Pediatric pedestrian injuries and associated hospital resource utilization in the United States, 2003

Kristen A Conner1, Lindsay E Williams, Lara B McKenzie

  • 1Center for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA.

The Journal of Trauma
|January 23, 2010
PubMed

Insights

Pediatric pedestrian injuries in the U.S. led to nearly 45,000 hospital days and over $290 million in charges in 2003. Higher injury severity and older age correlated with increased hospital costs and longer stays.

Area of Science:

  • Pediatric injury epidemiology
  • Healthcare resource utilization
  • Public health

Background:

  • Pedestrian injuries represent a significant public health concern for children.
  • Understanding the economic and resource impact of these injuries is crucial for prevention and intervention strategies.

Purpose of the Study:

  • To estimate national hospitalizations and healthcare resource use for pediatric pedestrian injuries.
  • To analyze sociodemographic, hospital, and injury severity factors influencing total charges and length of stay (LOS).

Main Methods:

  • Utilized the 2003 Healthcare Cost and Utilization Project Kids' Inpatient Database.
  • Analyzed data from 9,172 hospitalizations of patients aged 19 years and younger with pedestrian-related injuries.
  • Employed regression analyses to explore associations between covariates and hospital charges/LOS.

Main Results:

  • In 2003, pediatric pedestrian injuries resulted in 44,895 hospitalization days and $290.8 million in inpatient charges.
  • Traumatic brain injury (36%) and severe injuries (21%) were common. Traffic-related events caused 92.7% of hospitalizations.
  • Older age, higher injury severity, urban/Western location, children's hospital type, and longer LOS were linked to higher total charges.

Conclusions:

  • Pediatric pedestrian injuries impose a substantial healthcare burden in the U.S.
  • Factors like injury severity and patient demographics significantly impact healthcare resource consumption and costs.
Abstract

More Related Videos

Maintenance of a Lateral Fluid Percussion Injury Device05:16

Maintenance of a Lateral Fluid Percussion Injury Device

Published on: April 21, 2023

Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...